IRIS UniCatt

Bria, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.234
AS - Asia 5.398
EU - Europa 3.525
SA - Sud America 1.313
Continente sconosciuto - Info sul continente non disponibili 301
AF - Africa 153
OC - Oceania 7
Totale 17.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.980
SG - Singapore 2.355
BR - Brasile 1.101
CN - Cina 993
IT - Italia 964
VN - Vietnam 718
SE - Svezia 664
FR - Francia 376
DE - Germania 357
IN - India 318
BD - Bangladesh 209
GB - Regno Unito 189
PL - Polonia 189
IE - Irlanda 187
ID - Indonesia 158
FI - Finlandia 147
HK - Hong Kong 145
JP - Giappone 137
CA - Canada 103
RU - Federazione Russa 92
AR - Argentina 88
MX - Messico 83
NL - Olanda 77
IQ - Iraq 66
KR - Corea 52
ES - Italia 46
AT - Austria 41
TR - Turchia 40
ZA - Sudafrica 38
EC - Ecuador 33
UA - Ucraina 32
CI - Costa d'Avorio 31
PK - Pakistan 28
CO - Colombia 25
IR - Iran 24
CZ - Repubblica Ceca 23
VE - Venezuela 23
BE - Belgio 22
SA - Arabia Saudita 21
UZ - Uzbekistan 19
LT - Lituania 18
CH - Svizzera 16
EG - Egitto 16
JM - Giamaica 14
KE - Kenya 14
TN - Tunisia 14
CR - Costa Rica 13
PY - Paraguay 13
CL - Cile 12
JO - Giordania 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
PH - Filippine 11
PT - Portogallo 11
AL - Albania 9
DZ - Algeria 9
NP - Nepal 9
RO - Romania 9
AZ - Azerbaigian 8
BG - Bulgaria 8
BO - Bolivia 8
HU - Ungheria 8
TT - Trinidad e Tobago 8
AU - Australia 7
KZ - Kazakistan 6
LV - Lettonia 6
NI - Nicaragua 6
TW - Taiwan 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
HN - Honduras 5
LB - Libano 5
BB - Barbados 4
ET - Etiopia 4
EU - Europa 4
LU - Lussemburgo 4
PA - Panama 4
PE - Perù 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GD - Grenada 2
GE - Georgia 2
GG - Guernsey 2
HR - Croazia 2
HT - Haiti 2
Totale 17.602
Salva come PNG Salva come JPEG
Città #
Singapore 1.299
Ashburn 768
San Jose 681
Chandler 550
Rome 241
Ho Chi Minh City 237
Beijing 235
New York 213
Dublin 178
Hanoi 178
Warsaw 173
Fairfield 163
Hyderabad 156
Los Angeles 155
Hefei 139
Lauterbourg 136
Tokyo 134
Hong Kong 131
Council Bluffs 129
Jakarta 123
Chicago 118
Milan 118
The Dalles 116
Frankfurt am Main 104
Wilmington 103
Houston 102
São Paulo 102
Princeton 92
San Mateo 84
Helsinki 82
Seattle 82
Dallas 77
Munich 76
Boston 70
Santa Clara 66
Atlanta 60
Moscow 57
Woodbridge 57
Boardman 56
Seoul 50
Cambridge 48
St Louis 46
London 45
Buffalo 44
Ann Arbor 43
Cattolica 43
Paris 42
Marseille 40
Orem 40
Kent 38
Denver 35
Turku 34
Abidjan 31
Chennai 31
Lappeenranta 31
Phoenix 31
Da Nang 30
Bremen 29
Brooklyn 29
Haiphong 29
Rio de Janeiro 29
Mexico City 28
Nuremberg 28
Düsseldorf 26
San Francisco 26
Montreal 25
Redwood City 25
Toronto 25
Dearborn 24
Memphis 24
Poplar 24
Nanjing 23
Stockholm 23
Johannesburg 22
Brussels 21
Curitiba 20
Goiânia 20
North Bergen 20
Salt Lake City 20
Hải Dương 19
Jacksonville 19
Manchester 19
Vienna 19
Amsterdam 18
Campinas 18
Augusta 17
Dhaka 17
Tashkent 17
Baghdad 16
Belo Horizonte 16
Naples 16
Porto Alegre 16
Shanghai 16
Andover 15
Guangzhou 15
Brno 14
Hangzhou 14
Madrid 14
Quito 14
Redmond 14
Totale 9.226
Salva come PNG Salva come JPEG
Nome #
Survival analysis in single N2 station lung adenocarcinoma: The prognostic role of involved lymph nodes and adjuvant therapy 358
Pembrolizumab as first-line treatment for metastatic uveal melanoma 353
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 351
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 329
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 320
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort 299
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 273
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 255
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 228
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 214
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 203
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 200
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 191
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 188
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 177
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 174
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 170
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 169
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case series 166
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 163
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 160
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial 160
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 160
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 158
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 157
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 156
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 156
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 153
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 153
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" Study 152
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 152
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 150
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 148
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 147
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 146
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 145
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 143
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 140
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 140
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 140
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 138
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 137
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 137
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 135
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 130
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 129
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response 126
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 126
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 125
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy? 125
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 124
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers 124
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 123
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 123
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 122
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer 122
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 121
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 120
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 119
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 119
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 118
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 118
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review 115
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 114
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 114
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 113
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 112
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 112
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 112
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 112
Exploring the molecular and biological background of lung neuroendocrine tumours 111
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 110
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 110
Nutritional Support in Lung Cancer Patients: The State of the Art 110
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: The crucial role of histological type, number of resected nodes and adjuvant therapy 109
Collagenous colitis and atezolizumab therapy: an atypical case. 109
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 108
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study 107
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 105
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 104
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 104
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 104
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 99
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 98
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 98
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 97
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 97
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 97
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 96
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 96
Muscle derangement and alteration of the nutritional machinery in NSCLC 95
PTEN in colorectal cancer: Shedding light on its role as predictor and target 94
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors 92
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 92
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 92
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 91
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 88
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 88
ALK gene copy number gains in non-small-cell lung cancer: Prognostic impact and clinico-pathological correlations 87
Totale 14.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022807 0 39 18 101 37 38 23 139 48 27 157 180
2022/20231.699 266 207 134 241 75 201 99 125 176 57 67 51
2023/20241.055 36 250 39 49 41 114 108 53 17 56 128 164
2024/20253.079 88 42 204 99 177 80 152 117 460 453 639 568
2025/20268.571 1.016 324 606 1.286 1.288 359 1.278 408 560 526 409 511
2026/20271.519 434 1.085 0 0 0 0 0 0 0 0 0 0
Totale 17.931